Live Breaking News & Updates on Aza Substituted Psilocin Analogs

Stay updated with breaking news from Aza substituted psilocin analogs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds

Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , British Columbia , United Kingdom , Joshua Bartch , David Coffman George Duxberry , Health Canada , Mydecine Innovations Group , University Of Alberta , Analog Development , Trademark Office , Johns Hopkins University , Mydecine Innovations Group Inc , European Union Withdrawal , Corporate Advisornovum Securities , Innovations Group , United States Patent , Aza Substituted Psilocin Analogs , Same Unique , Market Abuse Regulation , European Union , Chief Executive Officer , Advisornovum Securities Limited , North America , Applied Pharmaceutical Innovation , Johns Hopkins ,

Mydecine Innovations Group Receives Two Notice of

VANCOUVER, British Columbia, Feb. 07, 2024 (GLOBE NEWSWIRE) Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (CSE:MYCO) (AQSE:MYIG). ....

British Columbia , United Kingdom , United States , David Coffman George Duxberry , Joshua Bartch , Trademark Office , Mydecine Innovations Group Inc , Johns Hopkins University , European Union Withdrawal , Mydecine Innovations Group , Health Canada , University Of Alberta , Novum Securities , Analog Development , Innovations Group , United States Patent , Aza Substituted Psilocin Analogs , Same Unique , Market Abuse Regulation , European Union , Chief Executive Officer , Securities Limited , North America , Applied Pharmaceutical Innovation , Johns Hopkins , Canadian Stock Exchange Myco Cn ,

Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds

VANCOUVER, British Columbia, Feb. 07, 2024 Mydecine Innovations Group Inc. , a leading biotechnology company dedicated to transforming mental health and addiction treatment, proudly. ....

United Kingdom , British Columbia , United States , Joshua Bartch , David Coffman George Duxberry , European Union Withdrawal , Mydecine Innovations Group Inc , Johns Hopkins University , Trademark Office , Analog Development , Novum Securities , University Of Alberta , Health Canada , Mydecine Innovations Group , Innovations Group , United States Patent , Aza Substituted Psilocin Analogs , Same Unique , Market Abuse Regulation , European Union , Chief Executive Officer , Securities Limited , North America , Applied Pharmaceutical Innovation , Johns Hopkins ,

Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds

Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds
businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , British Columbia , Joshua Bartch , David Coffman George Duxberry , European Union Withdrawal , Mydecine Innovations Group , Trademark Office , Novum Securities , Johns Hopkins University , Mydecine Innovations Group Inc , Health Canada , Analog Development , University Of Alberta , Innovations Group , United States Patent , Aza Substituted Psilocin Analogs , Same Unique , Market Abuse Regulation , European Union , Chief Executive Officer , Securities Limited , George Duxberry , North America , Applied Pharmaceutical Innovation , Johns Hopkins ,